INNOVATION PHARMACEUTICALS INC. Finite-lived Intangible Assets Acquired
INNOVATION PHARMACEUTICALS INC. reported Finite-lived Intangible Assets Acquired of $37.00 thousand for the 12-month period ending 2016-06-30, per its 10-K filed 2016-09-13.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2016-09-13
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for the quarter ending 2014-06-30 was $29.00K.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for the quarter ending 2014-03-31 was $107.00K.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for fiscal 2016 was $37.00K, a 63.73% decline from fiscal 2015.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for fiscal 2015 was $102.00K, a 25.00% decline from fiscal 2014.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for fiscal 2014 was $136.00K, a 368.97% increase from fiscal 2013.
- INNOVATION PHARMACEUTICALS INC. finite-lived intangible assets acquired for fiscal 2013 was $29.00K, a 70.71% decline from fiscal 2012.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month | Finite-lived Intangible Assets Acquired 12 month as first filed | Finite-lived Intangible Assets Acquired 72 month | Finite-lived Intangible Assets Acquired 75 month | Finite-lived Intangible Assets Acquired 78 month | Finite-lived Intangible Assets Acquired 81 month |
|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $37.00K 10-K · filed 2016-09-13 | ||||||||
| 2015-06-30 | $102.00K 10-K · filed 2016-09-13 | ||||||||
| 2014-06-30 | $29.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-09-13 | $136.00K derived: sum of 2 quarters · filed 2016-09-13 | $136.00K derived: sum of 3 quarters · filed 2016-09-13 | $136.00K 10-K · filed 2016-09-13 | |||||
| 2014-03-31 | $107.00K 10-Q/A · filed 2014-05-16 | $107.00K derived: sum of 2 quarters · filed 2014-05-16 | $107.00K 10-Q/A · filed 2014-05-16 | $107.00K derived: sum of 4 quarters · filed 2015-09-11 | $305.00K 10-Q/A · filed 2014-05-16 | ||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-10 | $0.00 10-Q · filed 2014-02-10 | $0.00 derived: sum of 3 quarters · filed 2015-09-11 | $0.00 derived: sum of 4 quarters · filed 2015-09-11 | $197.00K 10-Q · filed 2014-02-10 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2015-09-11 | $0.00 derived: sum of 3 quarters · filed 2015-09-11 | $20.00K derived: sum of 4 quarters · filed 2015-09-11 | $197.00K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-09-11 | $0.00 derived: sum of 2 quarters · filed 2015-09-11 | $20.00K derived: sum of 3 quarters · filed 2015-09-11 | $29.00K 10-K · filed 2015-09-11 | $28.82K 10-K · filed 2013-09-30 | $197.11K 10-K · filed 2013-09-30 | |||
| 2013-03-31 | $0.00 10-Q/A · filed 2014-05-16 | $20.00K derived: sum of 2 quarters · filed 2014-05-16 | $29.00K 10-Q/A · filed 2014-05-16 | ||||||
| 2012-12-31 | $20.00K 10-Q · filed 2014-02-10 | $29.00K 10-Q · filed 2014-02-10 | |||||||
| 2012-09-30 | $9.00K 10-Q · filed 2013-11-08 | ||||||||
| 2012-06-30 | $99.00K 10-K · filed 2014-09-15 | $98.61K 10-K · filed 2013-09-30 |